Propranolol, oxprenolol, and sclerosing peritonitis.
作者信息
Marigold J H, Pounder R E, Pemberton J, Thompson R P
出版信息
Br Med J (Clin Res Ed). 1982 Mar 20;284(6319):870. doi: 10.1136/bmj.284.6319.870.
Abstract
摘要
相似文献
1
Propranolol, oxprenolol, and sclerosing peritonitis.普萘洛尔、氧烯洛尔与硬化性腹膜炎
Br Med J (Clin Res Ed). 1982 Mar 20;284(6319):870. doi: 10.1136/bmj.284.6319.870.
2
Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers.
Q J Med. 1977 Jan;46(181):135-49.
3
Sclerosing encapsulating peritonitis associated with propranolol usage: a case report and review of the literature.
J Dig Dis. 2009 Nov;10(4):332-5. doi: 10.1111/j.1751-2980.2009.00405.x.
4
Sclerosing peritonitis and propranolol.
Chest. 1981 Mar;79(3):361-2. doi: 10.1378/chest.79.3.361.
5
Sclerosing peritonitis and propranolol.硬化性腹膜炎与普萘洛尔
Arch Intern Med. 1978 Sep;138(9):1424-6.
6
The acute and chronic effect of oxprenolol and propranolol on peripheral blood flow in hypertensive patients.氧烯洛尔和普萘洛尔对高血压患者外周血流的急慢性影响。
Br J Clin Pharmacol. 1982 Nov;14(5):733-7. doi: 10.1111/j.1365-2125.1982.tb04965.x.
7
Fibrinous peritonitis.纤维素性腹膜炎
Br Med J. 1977 Jun 18;1(6076):1598. doi: 10.1136/bmj.1.6076.1598-d.
8
Sclerosing peritonitis with short-term propranolol therapy.硬化性腹膜炎与短期普萘洛尔治疗
Arch Intern Med. 1980 Aug;140(8):1124-5.
9
Dermatitis caused by epichlorohydrin, oxprenolol hydrochloride and propranolol hydrochloride.由环氧氯丙烷、盐酸氧烯洛尔和盐酸普萘洛尔引起的皮炎。
Contact Dermatitis. 1990 Sep;23(3):199. doi: 10.1111/j.1600-0536.1990.tb04792.x.
10
Oxprenolol and propranolol in anxiety states. A double-blind comparative study.
S Afr Med J. 1976 Apr 10;50(16):627-9.
引用本文的文献
1
A Case Series and Brief Review of Literature on Encapsulating Peritoneal Sclerosis: Unveiling the Cocoon.关于包裹性腹膜硬化的病例系列及文献简要综述：揭开“茧”的面纱
Cureus. 2024 Nov 16;16(11):e73802. doi: 10.7759/cureus.73802. eCollection 2024 Nov.
2
Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.包裹性腹膜硬化症：发病机制与现行治疗选择。
Int J Mol Sci. 2019 Nov 16;20(22):5765. doi: 10.3390/ijms20225765.
3
Encapsulating peritoneal sclerosis in the new millennium: a national cohort study.新千年的包裹性腹膜硬化症：一项全国队列研究。
Clin J Am Soc Nephrol. 2009 Jul;4(7):1222-9. doi: 10.2215/CJN.01260209. Epub 2009 Jun 18.
4
Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea.透析相关硬化性包裹性腹膜炎的临床特征：韩国的多中心经验
Yonsei Med J. 2005 Feb 28;46(1):104-11. doi: 10.3349/ymj.2005.46.1.104.
5
Sclerosing encapsulating peritonitis.硬化性包裹性腹膜炎
Int Urol Nephrol. 1998;30(2):223-7. doi: 10.1007/BF02550581.
6
Review of general surgery 1982.《普通外科学综述》1982年版
Postgrad Med J. 1983 Jul;59(693):403-22. doi: 10.1136/pgmj.59.693.403.
本文引用的文献
1
Sclerosing peritonitis and propranolol.
Chest. 1981 Mar;79(3):361-2. doi: 10.1378/chest.79.3.361.
2
Untoward effects associated with practolol administration: oculomucocutaneous syndrome.与心得宁给药相关的不良反应：眼黏膜皮肤综合征。
Br Med J. 1975 Mar 15;1(5958):595-8. doi: 10.1136/bmj.1.5958.595.
3
Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers.
Q J Med. 1977 Jan;46(181):135-49.
4
Sclerosing peritonitis and propranolol.硬化性腹膜炎与普萘洛尔
Arch Intern Med. 1978 Sep;138(9):1424-6.
Zotero 插件